Clinical Trials

Janssen Reports Positive Phase 3 TREMFYA Data in Patients with Difficult-to-Treat PsA

Janssen Reports Positive Phase 3 TREMFYA Data in Patients with Difficult-to-Treat PsA

Dr. Soumya Chakravarty, MD, Ph.D., Senior Director & Strategic Lead, Rheumatology Therapeutic Area, U.S. Immunology Medical Affairs, Janssen Scientific Affairs, discusses the latest Phase 3 TREMFYA (guselkumab) data that was published in the “Annals of the Rheumatic Diseases” which demonstrated improvements in joint and skin symptoms in patients with difficult-to-treat psoriatic arthritis (PsA). The study results also show TREMFYA provided greater improvements in physical function and health-related quality of life scores compared to placebo. COSMOS is the first study to evaluate the safety and efficacy of an IL-23 inhibitor therapy in adults with active PsA and an inadequate response to tumor necrosis factor inhibition. 

Frequently Asked Questions

What is the main topic discussed in this episode of Health Professional Radio?

This episode covers important developments in healthcare, including updates on Arthritis. Health Professional Radio brings you expert insights and analysis on the latest medical news affecting healthcare professionals and patients alike.

How can healthcare professionals benefit from this information?

Healthcare professionals can stay informed about the latest developments in Arthritis and related fields, enabling them to provide better patient care. Staying current with medical news helps clinicians make evidence-based decisions in their practice.

Where can I find more information about Arthritis?

For more detailed information, listen to the full episode on Health Professional Radio and visit hpr.fm for additional resources. You can also subscribe to our podcast for regular updates on healthcare news and expert interviews.

Soumya D. Chakravarty, MD, ​Ph.D. serves as Senior Director & Strategic Lead, Rheumatology Therapeutic Area, U.S. Immunology Medical Affairs, Janssen Scientific Affairs, LLC. Soumya joined Janssen in April 2016 and prior to that, was an Assistant Professor of Medicine, Division of Rheumatology at Drexel University College of Medicine and Hahnemann University Hospital, both in Philadelphia, PA. Soumya was an active clinician and clinical investigator with a focus on inflammatory arthritis disease pathogenesis and currently holds an adjunct faculty appointment there, allowing him to maintain a continuity clinic to continue treating patients.

Soumya received his B.S. in Biochemistry from the University of Michigan. He received his MD and ​Ph.D. from the Albert Einstein College of Medicine of Yeshiva University in NY. He completed his internal medicine residency at ​New York Presbyterian Hospital—Weill Cornell Medical College and fellowship/instructorship in rheumatology at Hospital for Special Surgery, both in NY. He is a Fellow of both the American College of Physicians, as well as the American College of Rheumatology. Soumya, his wife Liz, and their daughters Carolina (6yrs), Mia (3yrs), and Madeline (6mos) live in Villanova, PA. Soumya is an ardent fan of Michigan sports and enjoys classic films and travel.

Last updated: January 20, 2022

Medical Disclaimer

The information provided on this website is for general informational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional for medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.